| Catalog Number |
761165 |
| Medical Device Problem Code |
Device Ingredient or Reagent Problem (2910)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/03/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that prior to using paxgene® blood dna tub, a pale-yellow coagulation was seen inside of two tubes.No adverse impact was reported regarding the patient or user.
|
| |
|
Additional Manufacturer Narrative
|
|
The following fields have been updated with corrected and/or additional information.D9: device available for evaluation: yes.H3: device eval by manufacturer? yes.D9: returned to manufacturer on: 29-oct-2025.Investigation summary: bd received three photographs and two samples for investigation.Evaluation of these photos and samples indicated an additive abnormality.Additionally, a total of 100 retained samples were visually inspected, and no additive abnormality was found.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.This complaint has been confirmed for the indicated failure mode: additive abnormality.No definitive root cause could be established for the reported defect.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for the identification of emerging trends.
|
| |
|
Event or Problem Description
|
|
It was reported that prior to using paxgene® blood dna tub, a pale-yellow coagulation was seen inside of two tubes.No adverse impact was reported regarding the patient or user.
|
| |
|
Search Alerts/Recalls
|